National Prostate Cancer Audit (NPCA) report

The National Cancer Audit Collaborating Centre (NATCAN) has published a State of the Nation report from the National Prostate Cancer Audit (NPCA) on the care received by people with prostate cancer in England and Wales from 1 January 2019 to 31 January 2023. Key messages include:

• The proportion of men diagnosed with high-risk/locally advanced prostate cancer undergoing radical prostate cancer treatment remained stable when comparing to 2019
• The proportion of men diagnosed with low-risk localised prostate cancer undergoing radical prostate cancer treatment was 8% in England and 9% in Wales
• There was an increase in men newly diagnosed with prostate cancer in 2022 in England, and in 2021 in Wales
• There was an increase in men newly diagnosed with prostate cancer treated with either radical prostatectomy or radiotherapy in 2022 in England
• The proportion of patients experiencing a genitourinary or gastrointestinal complication within two years of radical treatment remained stable in England and Wales, when comparing to 2015-2019
• There were changes in some aspects of prostate cancer treatment, including an increased utilisation of ultra-hypofractionated radiotherapy and a shift in the systemic agents used.

This report also contains a number of recommendations, detailed analysis and commentary.

Read the full report: You can view the report by clicking the buttons below.

Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.